title: Sustained effect of high-dose intrathecal baclofen in primary generalized dystonia: a 2-year follow-up study.
authors.affiliation: Department of Neurosciences, Centre Hospitalier de Luxembourg.
authors.forename: N J
authors.initials: NJ
authors.lastname: Diederich
authors.forename: C L
authors.initials: CL
authors.lastname: Comella
authors.forename: G
authors.initials: G
authors.lastname: Matge
authors.forename: G
authors.initials: G
authors.lastname: Becker
authors.forename: F
authors.initials: F
authors.lastname: Schiltz
authors.forename: H
authors.initials: H
authors.lastname: Metz
mesh_terms: D000328:Adult; D001418:Baclofen / Q000627:therapeutic use*; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D002408:Catheters, Indwelling; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004421:Dystonia / Q000188:drug therapy*; D005500:Follow-Up Studies; D006801:Humans; D015918:Infusion Pumps, Implantable; D008137:Longitudinal Studies; D008297:Male; D009125:Muscle Relaxants, Central / Q000627:therapeutic use*
chemical_list: D009125:Muscle Relaxants, Central; D019274:Botulinum Toxins, Type A; D001418:Baclofen